GLP-1 Medication Use Is Linked with Lower Anxiety, Depression Rates
- On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances of an anxiety or depression diagnosis. These drugs are prescribed and FDA-approved to promote weight loss in overweight or obese patients and manage...
